EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+50.75%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$492M
AUM Growth
+$492M
(+54%)
Cap. Flow
+$111M
Cap. Flow
% of AUM
22.65%
Top 10 Holdings %
Top 10 Hldgs %
53.05%
Holding
79
New
22
Increased
21
Reduced
20
Closed
8
Top Buys
| 1 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$20.3M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
$14.7M |
| 3 |
Pennant Group
PNTG
|
$12.3M |
| 4 |
Sanofi
SNY
|
$10.1M |
| 5 |
MDCO
Medicines Co
MDCO
|
$9.71M |
Top Sells
| 1 |
AMRN
Amarin Corp
AMRN
|
$8.88M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
$7.72M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$7.4M |
| 4 |
DexCom
DXCM
|
$7.11M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
$5.33M |
Sector Composition
| 1 | Healthcare | 86.78% |
| 2 | Real Estate | 1.94% |
| 3 | Communication Services | 1.48% |
| 4 | Industrials | 1.1% |
| 5 | Financials | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OXFD
26
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $5.81M | 1.03% |
349,823
+93,823
| +37% | +$1.56M |
|
|
RCM
27
DELISTED
R1 RCM Inc. Common Stock
RCM
| $5.41M | 0.96% |
416,726
-309,246
| -43% | -$4.01M |
|
28
Natera
NTRA
$23B
| $5.29M | 0.93% |
+157,081
| New | +$5.29M |
|
|
KDMN
29
DELISTED
Kadmon Holdings, Inc.
KDMN
| $5.17M | 0.91% |
+1,141,939
| New | +$5.17M |
|
30
Guardant Health
GH
$8.11B
| $5.06M | 0.89% |
+64,720
| New | +$5.06M |
|
31
Qiagen
QGEN
$10.1B
| $4.63M | 0.82% |
+137,000
| New | +$4.63M |
|
32
eHealth
EHTH
$126M
| $3.04M | 0.54% |
31,653
-11,000
| -26% | -$1.06M |
|
33
Omega Healthcare
OHI
$12.5B
| $3.03M | 0.53% |
71,500
-35,000
| -33% | -$1.48M |
|
34
Elevance Health
ELV
$72.4B
| $3.02M | 0.53% |
+10,000
| New | +$3.02M |
|
|
AGRX
35
DELISTED
Agile Therapeutics, Inc
AGRX
| $2.84M | 0.5% |
1,136,006
+226,521
| +25% | +$565K |
|
36
Xenon Pharmaceuticals
XENE
$2.99B
| $2.83M | 0.5% |
215,609
| – | – |
|
|
LTC
37
LTC Properties
LTC
$1.67B
| $2.66M | 0.47% |
59,327
-10,000
| -14% | -$448K |
|
|
38
DexCom
DXCM
$30.9B
| $2.64M | 0.47% |
12,050
-32,500
| -73% | -$7.11M |
|
39
Centene
CNC
$14.8B
| $2.51M | 0.44% |
+40,000
| New | +$2.51M |
|
|
IGMS
40
DELISTED
IGM Biosciences
IGMS
| $2.47M | 0.44% |
+64,600
| New | +$2.47M |
|
|
AFMD
41
DELISTED
Affimed
AFMD
| $2.35M | 0.42% |
857,771
+535,600
| +166% | +$1.47M |
|
42
Collegium Pharmaceutical
COLL
$1.25B
| $2.29M | 0.4% |
111,361
-48,934
| -31% | -$1.01M |
|
43
CareTrust REIT
CTRE
$7.53B
| $2.24M | 0.4% |
107,464
-30,000
| -22% | -$625K |
|
|
BDSI
44
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.12M | 0.37% |
335,485
-372,535
| -53% | -$2.35M |
|
|
OTIC
45
DELISTED
Otonomy, Inc.
OTIC
| $2.11M | 0.37% |
550,665
+174,323
| +46% | +$668K |
|
46
Aquestive Therapeutics
AQST
$478M
| $2.04M | 0.36% |
+350,000
| New | +$2.04M |
|
|
HSKA
47
DELISTED
Heska Corp
HSKA
| $1.99M | 0.35% |
20,771
-20,053
| -49% | -$1.92M |
|
|
ALBO
48
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $1.98M | 0.35% |
78,029
+60,000
| +333% | +$1.53M |
|
49
Cytokinetics
CYTK
$5.98B
| $1.93M | 0.34% |
181,700
| – | – |
|
|
TLGT
50
DELISTED
Teligent, Inc
TLGT
| $1.92M | 0.34% |
4,501,799
+77,577
| +2% | +$33K |
|